P20.1 Regulatory and HTA perspectives on real-world data in AD: Future of prospective collection and further research. Diana O’Rourke
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 116020 (“ROADMAP”). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Copyright ©2024 ROADMAP
